HopeStage
Back to all studies
CompletedNCT05557643

Psilocybin therapy and mindfulness for frontline healthcare burnout

About this titleRead the official source — NCT05557643
Medication studyAges 25+United StatesDepression
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 25 years.

Listed locations
Salt Lake CitySee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: January 2, 2023
Recruitment status
Completed
Enrollment listed in the registry
24
Sponsor
University of Utah
Sponsor type
University
Study type
Drug
Intervention type
Behavioural, Drug
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
Over 25 Years
Official registry ID
NCT05557643
Official title
Show the full official title

PAPR: Psilocybin-assisted Psychotherapy + Mindfulness-Based Stress Reduction (MBSR) for Front-line Healthcare Provider COVID-19 Related Burnout

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Salt Lake City

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Utah, a university.

Did this study involve medication?

Yes. The study involved medication, including Psilocybin.

Who was this study for?

Listed age limits: from 25 years.

Want to explore more studies?

Explore studies